A. Ashford

500 total citations
27 papers, 355 citations indexed

About

A. Ashford is a scholar working on Genetics, Molecular Biology and Pharmacology. According to data from OpenAlex, A. Ashford has authored 27 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in A. Ashford's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Pharmacology and Obesity Treatment (3 papers) and Receptor Mechanisms and Signaling (3 papers). A. Ashford is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers), Pharmacology and Obesity Treatment (3 papers) and Receptor Mechanisms and Signaling (3 papers). A. Ashford collaborates with scholars based in United Kingdom, France and United States. A. Ashford's co-authors include P. J. Southgate, M. Sandler, Vivette Glover, William R. Barclay, G M Stern, Thomas H. Giddings, D. A. T. New, Graham S. Bailey, C. E. Steele and Ayad A. Jaffa and has published in prestigious journals such as Nature, The Lancet and Journal of Medicinal Chemistry.

In The Last Decade

A. Ashford

26 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Ashford United Kingdom 11 107 59 58 48 39 27 355
Roberto P. Rosenkranz United States 12 188 1.8× 74 1.3× 51 0.9× 70 1.5× 43 1.1× 25 372
Yoshinori Aizu Japan 9 122 1.1× 30 0.5× 28 0.5× 6 0.1× 48 1.2× 10 449
J. Holá Czechia 13 75 0.7× 11 0.2× 61 1.1× 31 0.6× 29 0.7× 31 382
Kenneth V. Chace United States 11 256 2.4× 33 0.6× 21 0.4× 42 0.9× 74 1.9× 16 457
R M Graham United States 6 198 1.9× 63 1.1× 36 0.6× 49 1.0× 39 1.0× 7 412
Robert Vadnal United States 11 123 1.1× 58 1.0× 21 0.4× 10 0.2× 43 1.1× 20 353
D.A. Kalbhen Germany 13 140 1.3× 47 0.8× 140 2.4× 40 0.8× 88 2.3× 48 494
Yukio Takii Japan 16 353 3.3× 44 0.7× 17 0.3× 9 0.2× 72 1.8× 40 689
G. L. White United Kingdom 8 151 1.4× 62 1.1× 22 0.4× 6 0.1× 52 1.3× 12 364
Peter J. Korytko United States 9 177 1.7× 26 0.4× 21 0.4× 17 0.4× 38 1.0× 12 416

Countries citing papers authored by A. Ashford

Since Specialization
Citations

This map shows the geographic impact of A. Ashford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ashford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ashford more than expected).

Fields of papers citing papers by A. Ashford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ashford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ashford. The network helps show where A. Ashford may publish in the future.

Co-authorship network of co-authors of A. Ashford

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ashford. A scholar is included among the top collaborators of A. Ashford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ashford. A. Ashford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ashford, A., et al.. (2000). Electron microscopy may reveal structure of docosahexaenoic acid‐rich oil within Schizochytrium sp. Lipids. 35(12). 1377–1387. 32 indexed citations
2.
Barclay, William R., et al.. (1998). Production of Docosahexaenoic Acid from Microalgae and Its Benefits for Use in Animal Feeds. World review of nutrition and dietetics. 83. 61–76. 29 indexed citations
3.
Ashford, A., et al.. (1988). An investigation of the kallikrein—kinin system in normal and ischaemic rat hearts. Biochemical Society Transactions. 16(6). 1011–1012. 1 indexed citations
4.
Ashford, A., et al.. (1988). Effect of bradykinin and insulin on glucose oxidation in adipocytes from normal and streptozotocin diabetic rats. Biochemical Society Transactions. 16(6). 1012–1013. 3 indexed citations
5.
Jaffa, Ayad A., et al.. (1986). A Study of Glandular Kallikrein in Experimental Diabetes. Advances in experimental medicine and biology. 198 Pt B. 367–371.
6.
Ashton, Michael J., et al.. (1984). Heterocyclic analogs of chlorcyclizine with potent hypolipidemic activity. Journal of Medicinal Chemistry. 27(10). 1245–1253. 13 indexed citations
7.
Steele, C. E., et al.. (1983). Teratogenic action of hypolipidemic agents: An in vitro study with postimplantation rat embryos. Teratology. 28(2). 229–236. 14 indexed citations
8.
Sandler, M., et al.. (1980). The inhibition of tyramine oxidation and the tyramine hypertensive response (?cheese effect?) may be independent phenomena. Journal of Neural Transmission. 48(4). 241–247. 24 indexed citations
9.
Lant, AF, et al.. (1976). Comparative effects of acebutolol and practolol on the lipolytic response to isoprenaline.. British Journal of Clinical Pharmacology. 3(1). 177–184. 9 indexed citations
10.
Brown, George R., et al.. (1972). Basic ethers of 2-anilinobenzothiazoles and 2-anilinobenzoxazoles as potential antidepressants. Journal of Medicinal Chemistry. 15(5). 523–529. 9 indexed citations
11.
Ashford, A., et al.. (1971). Phenacylthioimidazolines and 3-aryl-5,6-dihydroimidazo[2,1-b]thiazoles with antidepressant activity. Journal of Medicinal Chemistry. 14(10). 977–982. 34 indexed citations
12.
Ashford, A., et al.. (1971). The effects of Arvin on pregnancy in the mouse and the rabbit. Toxicology and Applied Pharmacology. 20(4). 460–473. 19 indexed citations
13.
Ashford, A., et al.. (1970). The effect of Arvin on reticulo‐endothelial activity in rabbits. British Journal of Pharmacology. 40(1). 37–44. 3 indexed citations
14.
Archer, R. K., et al.. (1969). The Anticoagulant Effect of Arvin on Horse Blood. Equine Veterinary Journal. 1(4). 161–164. 2 indexed citations
15.
Ashford, A., et al.. (1968). PHARMACOLOGY AND TOXICOLOGY OF A DEFIBRINATING SUBSTANCE FROM MALAYAN PIT VIPER VENOM. The Lancet. 291(7541). 486–489. 46 indexed citations
16.
Ashford, A., et al.. (1968). Toxicity of depressant and antidepressant drugs in hyperthyroid mice.. BMJ. 2(5599). 217–218. 8 indexed citations
17.
Ashford, A., et al.. (1967). The effect of reserpine and α-methyldopa on the analgesic action of morphine in the mouse. Journal of Pharmacy and Pharmacology. 19(11). 709–713. 20 indexed citations
18.
Ashford, A., et al.. (1965). Effect of adrenalectomy on cotton pellet granuloma formation in the rat. Journal of Pharmacy and Pharmacology. 17(1). 10–14. 7 indexed citations
19.
Ashford, A., et al.. (1963). Thymol Basic Ethers and Related Compounds: Central Nervous System Depressant Action. Nature. 197(4871). 969–971. 2 indexed citations
20.
Ashford, A., et al.. (1962). EFFECT OF CHLORPROMAZINE, RESERPINE, BENACTYZINE AND PHENOBARBITONE ON THE RELEASE OF CORTICOTROPHIN IN THE RAT. British Journal of Pharmacology and Chemotherapy. 19(3). 458–463. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026